Connect Biopharma Holdings growth metrics data for the quarter ended Jun 2026. These growth metrics cover 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2024 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|
| Growth Ratios | ||||||
| EBITDA Margin Growth (1y) | -10.93M | 2.73M | ||||
| EBITDA Margin (QoQ) | -0.02M | -8.25M | 1.10M | |||
| EBIT Margin Growth (1y) | -10.93M | 2.73M | ||||
| EBIT Margin (QoQ) | -0.02M | -8.25M | 1.10M | |||
| EBT Margin Growth (1y) | -10.61M | 2.61M | ||||
| EBT Margin (QoQ) | -0.02M | -8.04M | 1.08M | |||
| FCF Margin Growth (1y) | -10.79M | 2.63M | ||||
| FCF Margin (QoQ) | 0.07M | -8.21M | 0.89M | |||
| Net Margin Growth (1y) | -10.64M | 2.62M | ||||
| Net Margin (QoQ) | -0.02M | -8.06M | 1.09M | |||
| Operating Margin Growth (1y) | -10.93M | 2.73M | ||||
| Operating Margin (QoQ) | -0.02M | -8.25M | 1.10M | |||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -0.01M | -0.01M | ||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | |
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -0.01M | -0.01M | ||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | |
| Return on Sales [ROS] Growth (1y)ROS Growth (1y) | -10.93M | -8.94M | 2.73M | |||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | -0.02M | -8.25M | 1.97M | 7.91M | 1.10M |